Annual Current Assets
$36.37 M
-$19.12 M-34.46%
01 December 2023
Summary:
COSCIENS Biopharma annual total current assets is currently $36.37 million, with the most recent change of -$19.12 million (-34.46%) on 01 December 2023. During the last 3 years, it has fallen by -$34.45 million (-48.65%).CSCI Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$28.22 M
-$4.99 M-15.02%
01 September 2024
Summary:
COSCIENS Biopharma quarterly total current assets is currently $28.22 million, with the most recent change of -$4.99 million (-15.02%) on 01 September 2024. Over the past year, it has increased by +$17.03 million (+152.16%).CSCI Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +152.2% |
| 3 y3 years | -48.6% | +190.0% |
| 5 y5 years | +233.3% | +475.0% |
CSCI Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -77.8% | -15.0% |
COSCIENS Biopharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.22 M(-15.0%) |
| June 2024 | - | $33.21 M(+277.2%) |
| Mar 2024 | - | $8.80 M(-21.3%) |
| Dec 2023 | $649.00 K(+20.6%) | $11.19 M(-15.5%) |
| Sept 2023 | - | $13.25 M(-3.7%) |
| June 2023 | - | $13.76 M(-6.8%) |
| Mar 2023 | - | $14.76 M(-2.7%) |
| Dec 2022 | $538.00 K(-94.2%) | $15.17 M(+12.1%) |
| Sept 2022 | - | $13.54 M(+2.0%) |
| June 2022 | - | $13.28 M(+14.8%) |
| Mar 2022 | - | $11.57 M(+18.9%) |
| Dec 2021 | $9.28 M(-1.2%) | $9.73 M(+4.9%) |
| Sept 2021 | - | $9.28 M(+9.3%) |
| June 2021 | - | $8.49 M(+14.3%) |
| Mar 2021 | - | $7.43 M(+4.6%) |
| Dec 2020 | $9.39 M(+3.5%) | $7.10 M(+0.4%) |
| Sept 2020 | - | $7.07 M(+7.9%) |
| June 2020 | - | $6.55 M(+23.8%) |
| Mar 2020 | - | $5.29 M(+7.7%) |
| Dec 2019 | $9.07 M(+3.6%) | $4.91 M(+8.1%) |
| Sept 2019 | - | $4.54 M(+3.8%) |
| June 2019 | - | $4.38 M(-1.8%) |
| Mar 2019 | - | $4.46 M(-1.0%) |
| Dec 2018 | $8.76 M(-31.7%) | $4.50 M(-4.9%) |
| Sept 2018 | - | $4.74 M(-22.9%) |
| June 2018 | - | $6.15 M(-4.0%) |
| Mar 2018 | - | $6.40 M(-10.5%) |
| Dec 2017 | $12.81 M(+43.7%) | $7.15 M(-18.0%) |
| Sept 2017 | - | $8.73 M(+6.3%) |
| June 2017 | - | $8.21 M(-1.2%) |
| Mar 2017 | - | $8.31 M(-2.0%) |
| Dec 2016 | $8.92 M(-2.1%) | $8.48 M(-1.1%) |
| Sept 2016 | - | $8.57 M(+226.9%) |
| June 2016 | - | $2.62 M(-2.3%) |
| Mar 2016 | - | $2.68 M(-3.2%) |
| Dec 2015 | $9.10 M(-18.8%) | $2.77 M(+45.3%) |
| Sept 2015 | - | $1.91 M(-7.8%) |
| June 2015 | - | $2.07 M(+30.8%) |
| Mar 2015 | - | $1.58 M(+11.4%) |
| Dec 2014 | $11.22 M(-17.2%) | $1.42 M(-16.7%) |
| Sept 2014 | - | $1.70 M(-26.8%) |
| June 2014 | - | $2.33 M(+6.3%) |
| Mar 2014 | - | $2.19 M(-25.9%) |
| Dec 2013 | $13.54 M(-5.7%) | $2.96 M(+65.9%) |
| Sept 2013 | - | $1.78 M(-8.1%) |
| June 2013 | - | $1.94 M(-7.6%) |
| Mar 2013 | - | $2.10 M(-12.1%) |
| Dec 2012 | $14.36 M(-5.7%) | $2.39 M(+29.6%) |
| Sept 2012 | - | $1.84 M(+33.5%) |
| June 2012 | - | $1.38 M(-28.5%) |
| Mar 2012 | - | $1.93 M(+5.8%) |
| Dec 2011 | $15.23 M(-53.0%) | $1.83 M(+28.0%) |
| Sept 2011 | - | $1.43 M(-6.8%) |
| June 2011 | - | $1.53 M(+3.6%) |
| Mar 2011 | - | $1.48 M(+33.5%) |
| Dec 2010 | $32.40 M | $1.11 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $1.15 M(+30.8%) |
| June 2010 | - | $881.30 K(-8.9%) |
| Mar 2010 | - | $967.10 K(+19.7%) |
| Dec 2009 | $37.25 M(-20.1%) | $807.70 K(-31.8%) |
| Sept 2009 | - | $1.19 M(+8.9%) |
| June 2009 | - | $1.09 M(+28.3%) |
| Mar 2009 | - | $848.80 K(-2.3%) |
| Dec 2008 | $46.62 M(-26.9%) | $869.10 K(-11.6%) |
| Sept 2008 | - | $982.70 K(-25.5%) |
| June 2008 | - | $1.32 M(-23.1%) |
| Mar 2008 | - | $1.71 M(-25.4%) |
| Dec 2007 | $63.78 M(-47.6%) | $2.30 M(-6.0%) |
| Sept 2007 | - | $2.45 M(-33.8%) |
| June 2007 | - | $3.69 M(+176.3%) |
| Mar 2007 | - | $1.34 M(+21.4%) |
| Dec 2006 | $121.77 M(-52.5%) | $1.10 M(-2.7%) |
| Sept 2006 | - | $1.13 M(-34.1%) |
| June 2006 | - | $1.72 M(+6.6%) |
| Mar 2006 | - | $1.61 M(+7.7%) |
| Dec 2005 | $256.11 M(+50.5%) | $1.50 M(+109.3%) |
| Sept 2005 | - | $715.50 K(-20.6%) |
| June 2005 | - | $901.60 K(-1.3%) |
| Mar 2005 | - | $913.50 K(+17.7%) |
| Dec 2004 | $170.13 M(+36.9%) | $776.40 K(+53.7%) |
| Sept 2004 | - | $505.00 K(-44.8%) |
| June 2004 | - | $915.40 K(+32.4%) |
| Mar 2004 | - | $691.30 K(-1.3%) |
| Dec 2003 | $124.26 M(+26.6%) | $700.30 K(+24.7%) |
| Sept 2003 | - | $561.50 K(+58.7%) |
| June 2003 | - | $353.90 K(+31.7%) |
| Mar 2003 | - | $268.70 K(+13.8%) |
| Dec 2002 | $98.16 M(+239.6%) | $236.20 K(-21.8%) |
| Sept 2002 | - | $302.10 K(-12.1%) |
| June 2002 | - | $343.70 K(+64.8%) |
| Mar 2002 | - | $208.60 K(+21.8%) |
| Dec 2001 | $28.90 M(+89.0%) | $171.20 K(-25.7%) |
| Sept 2001 | - | $230.30 K(+1.9%) |
| June 2001 | - | $226.10 K(+11.3%) |
| Mar 2001 | - | $203.20 K(+68.8%) |
| Dec 2000 | $15.29 M(+34.1%) | $120.40 K(-57.6%) |
| Sept 2000 | - | $283.80 K(+5.1%) |
| June 2000 | - | $270.10 K(+30.8%) |
| Mar 2000 | - | $206.50 K(+49.5%) |
| Dec 1999 | $11.40 M(+70.4%) | $138.10 K(+1.4%) |
| Sept 1999 | - | $136.20 K(+0.4%) |
| June 1999 | - | $135.70 K(-31.7%) |
| Mar 1999 | - | $198.80 K(+52.9%) |
| Dec 1998 | $6.69 M(+316.5%) | $130.00 K(-33.8%) |
| Sept 1998 | - | $196.50 K(-27.8%) |
| June 1998 | - | $272.30 K(+28.9%) |
| Mar 1998 | - | $211.30 K(+0.8%) |
| Dec 1997 | $1.61 M(+144.8%) | $209.60 K(-91.2%) |
| Sept 1997 | - | $2.39 M(-8.4%) |
| June 1997 | - | $2.61 M(-29.4%) |
| Mar 1997 | - | $3.70 M |
| Dec 1996 | $656.70 K | - |
FAQ
- What is COSCIENS Biopharma annual total current assets?
- What is the all time high annual current assets for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly total current assets?
- What is the all time high quarterly current assets for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly current assets year-on-year change?
What is COSCIENS Biopharma annual total current assets?
The current annual current assets of CSCI is $36.37 M
What is the all time high annual current assets for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual total current assets is $163.68 M
What is COSCIENS Biopharma quarterly total current assets?
The current quarterly current assets of CSCI is $28.22 M
What is the all time high quarterly current assets for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly total current assets is $33.21 M
What is COSCIENS Biopharma quarterly current assets year-on-year change?
Over the past year, CSCI quarterly total current assets has changed by +$17.03 M (+152.16%)